What's new

Human medicines European public assessment report (EPAR): Mvabea, Ebola vaccine (MVA-BN-Filo [recombinant]), Date of authorisation: 01/07/2020, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Mvabea, Ebola vaccine (MVA-BN-Filo [recombinant]), Date of authorisation: 01/07/2020, Revision: 6, Status: Authorised

Apr 7, 2025 - 16:15
 0
Human medicines European public assessment report (EPAR): Mvabea, Ebola vaccine (MVA-BN-Filo [recombinant]), Date of authorisation: 01/07/2020, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Mvabea, Ebola vaccine (MVA-BN-Filo [recombinant]), Date of authorisation: 01/07/2020, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

German research institute launches program to match threatened NIH grants with p...

Next Article

Altitude Secures +25,000 Tons Of CDRs From West African Suppliers

Related Posts

Human medicines European public assessment report (EPAR): Omvoh, mirikizumab, Date of authorisation: 26/05/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 21, 2025  0

Veterinary medicines European public assessment report (EPAR): Bluevac-3, bluetongue virus vaccine (inactivated), Status: Authorised

Veterinary medicines European public assessment report ...

Mar 5, 2025  0

EMEA-003514-PIP01-23

EMEA-003514-PIP01-23

Mar 18, 2025  0